Previous close | 6.57 |
Open | 6.78 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 6.68 - 7.00 |
52-week range | 3.72 - 8.69 |
Volume | |
Avg. volume | 34,943 |
Market cap | 87.377M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | 28.29 |
EPS (TTM) | 0.24 |
Earnings date | 02 May 2024 |
Forward dividend & yield | 0.16 (2.44%) |
Ex-dividend date | 31 May 2024 |
1y target est | N/A |
SALT LAKE CITY, May 06, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer, and Carl Aure, Chief Financial Officer, will participate in the Sidoti Micro Cap Conference, to be held May 8-9, 2024. Mr. Fife and Mr. Aure will meet with investors and present at approximately 1:00 p.m. Eastern Time o
LifeVantage ( NASDAQ:LFVN ) Third Quarter 2024 Results Key Financial Results Revenue: US$48.2m (down 10% from 3Q 2023...
LifeVantage Corporation (NASDAQ:LFVN) Q3 2024 Earnings Call Transcript May 3, 2024 LifeVantage Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, ladies and gentlemen. Thank you for standing by. Welcome to today’s Conference Call to discuss LifeVantage’s Third […]